Board of Directors
Dennis P. Andrulis, MPH, PhD (Chair)
Dr. Andrulis is a Senior Research Scientist at theTexas Health Institute in Austin, Texas. He is the co-founder of the National Conference Series on Quality Health Care for Culturally Diverse Populations. He is a national expert on diversity and preparedness; disparities and healthcare reform; primary care for the uninsured; vulnerable populations and their providers; suburbanization of poverty; cultural competence; and public health performance measures.
Before joining the Texas Health Institute, Dr. Andrulis served as the Associate Dean of Research and Director of the Center for Health Equality at Drexel University’s School of Public Health in Philadelphia. While at Drexel, he created The Drexel-Health Partners Seminar Series on Innovations to Reduce Disparities in Health Care, which provides students and health community members with opportunities to learn from noted leaders in this field.
Immediately prior to joining Drexel University, Dr. Andrulis was a research professor at Downstate Medical Center in Brooklyn, where he oversaw projects, prepared major reports, and published on issues affecting urban communities, the uninsured, and other vulnerable populations. From 1988 to 1996, he served as the president of theNational Public Health and Hospital Institute (NPHHI), a private, nonprofit organization established to address the major issues facing public hospitals, safety net organizations, underserved communities, and related health policy issues of national priority.
Dr. Andrulis co-authored “Managed Care in the Inner City” and created a cultural competence self-assessment tool for healthcare organizations. He has also developed a compendium and analysis of national data sources on the nation’s 100 largest cities and their surrounding areas titled “The Social and Health Landscape of Urban and Suburban America.” Dr. Andrulis has served on the AIHA Board of Directors since 1992.
Mary Lynn Carver
Mary Lynn Carver is a communications executive with more than 25 years of experience in a variety of corporate and nonprofit organizations. Since 2015, Ms. Carver has served as the Chief Communications Officer and Vice President of Global Corporate Communications at General Mills in Minneapolis, Minnesota. In this capacity, she is responsible for global communications strategy, including external, employee, corporate, and executive communications, as well as brand PR and crisis communications.
Prior to joining General Mills, Ms. Carver served as Senior Vice President of Communications & Public Affairs and was the first Chief Communications Officer for the University of Maryland Medical System, a rapidly expanding 12-hospital system with annual revenues in excess of $3 billion. From 2010-2015, she led the development of the organization’s communications strategy and 3-5 year plan and directed all aspects of internal and external communications, including media relations, brand and issues management, publications, and web, social media, and public affairs strategies.
Ms. Carver was Senior Vice President of Communications & Public Relations at St. Jude Children’s Research Hospital (2009-2010), where she led the development and restructuring of the communications strategy to more effectively link scientific and research communications with fundraising activities and strategic plans. Her work also included supporting the launch of the Pediatric Genome Project with St. Jude and Washington University and Board communications related to the development of St. Jude’s 25th anniversary plan.
Previous experience includes multiple positions with AstraZeneca Pharmaceuticals from 1998-2009, including serving as the Group Head of Global Internal Communications in London; Executive Director for Corporate Communications of the Global Oncology Division in Wilmington, Delaware; and Senior Director of Brand Communications for Oncology. While at AstraZeneca, Ms. Carver led the company’s external communications strategy for its multi-brand oncology drug portfolio and was responsible for the administration of the AstraZeneca Breast Cancer Foundation, which entailed working with patient advocacy groups, managing the grant request process, and developing strategic plans and budgets. Her early career was spent in a technology start-up in Texas.
Charles R. Evans, FACHE
Charles R. Evans is President of the International Health Services Group (IHSG), a social enterprise he founded in 2007 to support health services development in underserved areas of the world. IHSG’s objective is to collaborate with established organizations to supplement their capabilities in healthcare management and development as they work to achieve their broader missions. Current projects are located in sub-Saharan Africa and Latin America. IHSG also founded and supports the Leadership Corps for management capacity building. Finally, IHSG is active in encouraging international hospital partnerships between U.S. hospitals and hospitals in economically developing countries.
Mr. Evans is a Senior Advisor at Jackson Healthcare, an Atlanta-based consortium of companies that provide physician and clinician staffing, anesthesia management, and healthcare information technology solutions proven to improve clinical and financial outcomes to hospitals, health systems and physician groups throughout the United States.
Mr. Evans serves as a member of the boards at Jackson Healthcare, MiMedx Group, AnewMed, and Arena. Additionally, he serves on the boards of non-profit organizations including MedShare International, Hospital Charitable Service Awards, and FaithBridge Foster Care. He also serves as a member of the Global Group for Healthcare Partnerships and the International Hospital Federation’s Healthcare Management Special Interest Group. He was recently recognized by the International Hospital Federation as an honorary member.
In 2012, Mr. Evans attained the Board Leadership Fellow credential of the National Association of Corporate Directors. He is an honorary member of the International Hospital Federation and a Fellow in the American College of Healthcare Executives, where he served as a Governor of the College (2004-2007), Chairman Officer (2008-2011), and was the recipient of the 2014 ACHE Gold Medal Award – the highest honor the organization bestows. He currently serves as Special Advisor to ACHE on International Affairs.
Other professional experience includes managing company divisions including North Carolina, MidAmerica, and Southeast for the Hospital Corporation of America (HCA), as well as serving as President of the Eastern Group. Prior to joining HCA, Evans served in executive positions at Memorial Medical Center of Jacksonville (Florida) and Community Hospitals, Indianapolis, Indiana. While at Jacksonville, Mr. Evans and his team participated in an AIHA hospital strengthening partnership with Murmansk, Russia.
Derek Feeley became President and CEO of the Institute for Healthcare Improvement in January 2016. He previously served as IHI’s Executive Vice President from 2013 to 2015, during which time he had executive-level responsibility for driving IHI’s strategy in five focus areas: Improvement Capability; Person- and Family-Centered Care; Patient Safety; Quality, Cost, and Value; and the Triple Aim.
Prior to joining IHI in 2013, Mr. Feeley served as Director General for Health and Social Care in the Scottish Government and Chief Executive of the National Health Services (NHS) in Scotland (2010-2011). In that role, he was the principal advisor to the Scottish Government on health and healthcare policy, as well as on public service improvement. He also provided leadership to NHS Scotland’s 140,000 staff in their delivery of high-quality healthcare services.
Mr. Feeley spent the previous decade in various Scottish civil service positions, providing advice to ministers on issues as diverse as local government finance, fisheries, and human resource management. He served as principal private secretary and chief of staff to Scotland’s First Minister (2002-2004). He then worked as head of National Planning for the National Health Service and Director of Healthcare Policy and Strategy before assuming the role of Director General. He was also a Commonwealth Fund Harkness Fellow in Health Care Policy (2005-2006), spending his fellowship conducting case studies related to improving chronic disease management at Kaiser Permanente and the Veterans Health Administration.
Mr. Feeley is a business graduate from the University of Stratchclyde. In 2013, Mr. Feeley was made a Companion of the Order of the Bath by Her Majesty, Queen Elizabeth II, in recognition of his services to health and healthcare.
David Greeley (ex officio)
As AIHA’s President and CEO, Mr. David Greeley is responsible for setting and carrying out the organization’s vision; managing its programs, personnel, and finances; and increasing its visibility and resources.
Mr. Greeley has close to 20 years of experience with international nonprofit health and development organizations and more than 10 years of experience in the private sector. Immediately prior to joining AIHA, he served as President and CEO of Accordia Global Health Foundation. As the flagship corporate responsibility program of the pharmaceutical company Pfizer, Inc., Accordia’s mission is to improve healthcare capacity in Africa. Over the past decade, the Foundation established and helped develop the now renowned Infectious Disease Institute (IDI) in Uganda.
Previously, Mr. Greeley served as Senior Vice President of External Affairs for the Global Alliance for TB Drug Development (TB Alliance), a product development partnership working to bring new tuberculosis treatments to the market. At the TB Alliance, he was responsible for resource mobilization, policy and advocacy, community engagement, and the integration of communications into the external affairs agenda. Prior to the TB Alliance, Mr. Greeley served as Vice President for the Center for Private Sector Health Initiatives at AED, (which subsequently became FHI360), where he managed a team of some 50 individuals and a project portfolio of approximately $35 million annually. The Center’s projects spanned malaria, reproductive health, and HIV/AIDS, and operated in Asia, Africa, and the Caribbean.
From 1998-2008, Mr. Greeley worked for Merck & Co. Inc., first leading the public affairs, communications, and policy function for the Latin American division and then heading up the company’s global HIV/AIDS programs, policy, and stakeholder relations within the Office of Corporate Responsibility. Prior to Merck, he worked for Population Services International (PSI) for more than seven years. There he created the organization’s new business development department and led operations in India before being tapped to oversee PSI programming throughout Asia, as well as the business development department. At CARE, Mr. Greeley worked in Indonesia, Belize, and Niger in various programmatic and management capacities. He served as a Peace Corps Volunteer in Burkina Faso, West Africa, in the early 1980s.
Mr. Greeley has health expertise in HIV/AIDS, TB, malaria, family planning, maternal and child health, and building healthcare capacity, as well as experience in public affairs, communications, policy and advocacy, developing public-private partnerships, resource mobilization, and program and financial management. He has travelled to more than 90 countries and worked in Africa, Asia, Latin America, and the United States, including extended stays in Burkina Faso, Niger, the Democratic Republic of Congo, India, and Indonesia. He has a Master’s Degree in International Relations from Columbia University with a dual degree in Economic and Political Development and African Affairs.
Muhammad Ali Pate, MD, MBA
Dr. Muhammad Ali Pate currently serves as Chief Executive Officer of Big Win Philanthropy, a foundation that invests in maternal, child, and reproductive health, nutrition, and education, among other areas. He is an adjunct professor with the Duke Global Health Institute at Duke University in Durham, North Carolina and served as the 2016 R.L. Menschel Senior Leadership fellow at Harvard University’s Chan School of Public Health.
From 2011 to 2013, Dr. Pate served as Minister of State for Health in Nigeria, where he helped mobilize more than US$1 billion in additional financing for primary health care, implemented innovative programs such as prevention of mother-to-child transmission of HIV, clinical governance, and chaired the Presidential Task Force on Polio Eradication. He led Nigeria’s Saving One Million Lives Initiative and previously served as Executive Director of the National Primary Health Care Development Agency from 2008-2011.
Dr. Pate served as co-chair of the Harvard-London School of Hygiene and Tropical Medicine panel to review and advise the global health system on the lessons learned from the 2014 West African Ebola Outbreak. Since June 2010, Dr. Pate has co-chaired the Private Sector Health Alliance of Nigeria, which raised US$24 million domestically for investments to complement the Nigerian government’s Saving One Million Lives Initiative.
Prior to his public service in Nigeria, Dr. Pate worked at the World Bank as a senior public health specialist overseeing programs in Africa and the East Asia and Pacific region.
Earlier in his career, Dr. Pate served as a resident physician at Howard University Hospital in Washington, D.C. He completed a sub-specialty fellowship in infectious diseases at the University of Rochester Medical Center in upstate New York. He also served as a medical officer in Nigeria and with the British Medical Research Council Laboratories in The Gambia.
He earned a medical degree in 1990 from Ahmadu Bello University in Nigeria, an MBA with a health sector concentration from Duke University, and a Master of Science in Health System Management from the London School of Hygiene and Tropical Medicine.
Dr. Pate has been honored with numerous global health awards, including the 2012 Harvard Health Leadership Award, and has authored or contributed to dozens of peer reviewed publications and books.
Sheila A. Ryan, PhD, RN
Dr. Ryan is professor and the Charlotte Peck Lienemann and Distinguished Alumni Chair, as well as Director of International Programs in Nursing, at the University of Nebraska Medical Center College of Nursing in Omaha.
Dr. Ryan recently completed board service for theInstitute for Healthcare Improvement and theRobert Wood Johnson Institute of MedicineHealth Policy Fellow Selection Committee. She is a Fellow of the American Academy of Nursingand an elected member of the Institute of Medicine of the National Academies.
Dr. Ryan’s career includes some 25 years experience as dean of two nursing schools: the University of Rochester School of Nursing andCreighton University in Omaha, Nebraska. Dr. Ryan earned her BSN from the University of Nebraska (1969), her MSN in Psychiatric Nursing from the University of California-San Francisco (1971), and her PhD in clinical nursing research from the University of Arizona (1981).
Dr. Ryan joined the AIHA Board of Directors in 2000. She served as treasurer and chair of the finance and audit committee from 2004 to 2008 and is the current Board chairman.
Alan Weinstein, MBA (Treasurer; Chair, Finance & Audit Committee; Acting Secretary)
During his 35 year career in the U.S. health industry, Mr. Weinstein has focused on developing start-up businesses by providing services to hospitals through shared programs intended to achieve greater economies of scale.
Over the past 16 years, Mr. Weinstein’s has primarily served as an advisor or board member of health-related companies that sell goods or services to healthcare providers. His consultant services since 2000 have provided insights into hospital organization and management for supplier and services clients. He has provided sales and marketing guidance to many companies and has also assisted companies in the creation of advisory boards, advising on their structure and compensation arrangements, as well as the identification and selection of prospective candidates for these positions.
Mr. Weinstein was the founder and President of Premier Inc.; founder and President and Chief Executive Officer of the Premier Health Alliance; and executive vice president of the Illinois Hospital Association.
His current board and advisory positions include Akorn Pharmaceuticals, OpenMarkets, Champion Healthcare Technologies, Rendina Healthcare Real Estate, and the Rosalind Franklin University of Medicine and Science. Mr. Weinstein has been a member of AIHA’s Board of Directors since 1992.
M. Roy Wilson, MD
M. Roy Wilson, M.D., M.S. currently serves as President of Wayne State University. Prior to joining Wayne State, Dr. Wilson served as deputy director for strategic scientific planning and program coordination at the National Institute on Minority Health and Health Disparities (NIMHD) of the National Institutes of Health (NIH).
As deputy director, Dr. Wilson led the development and implementation of an integrated system for planning, coordinating, and evaluating the NIH health disparities research portfolio, in collaboration with the NIH institutes and centers. He also co-chaired the NIH Common Fund programs: the Building Infrastructure Leading to Diversity Initiative and the National Research Mentoring Network.
Previously, Dr. Wilson was dean of the School of Medicine and vice president for health sciences at Creighton University; president of the Texas Tech University Health Sciences Center; and, concurrently, chancellor of the University of Colorado Denver and chair of the Board of Directors of University of Colorado Hospital. Immediately prior to joining the NIH, Dr. Wilson chaired the Board of Directors of Charles R. Drew University of Medicine and Science and was acting president during part of that time. Under Dr. Wilson’s leadership, the university regained full institutional accreditation and stabilized its finances.
Dr. Wilson’s research has focused on glaucoma and blindness in populations from the Caribbean to West Africa. He holds elected memberships in the Institute of Medicine of the National Academy of Sciences, the International Glaucoma Research Society, and the American Ophthalmological Society. He has served on the executive committee of the NIH-funded Ocular Hypertension Treatment Study and currently chairs the Data Monitoring and Oversight Committee of the NIH-funded Los Angeles Latino Eye Study. Dr. Wilson was a member of the advisory councils of both NIMHD and the former National Center for Research Resources, as well as the NIH Director’s Working Group on Diversity in the Biomedical Research Workforce.
Dr. Wilson received his undergraduate degree from Allegheny College; an M.S. in epidemiology from the University of California, Los Angeles; and an M.D. from Harvard Medical School. He was selected for the list of Best Doctors in America for a consecutive 14 years by Best Doctors Inc. and was a finalist for the Los Angeles Business Journal’s Healthcare CEO of the Year in 2011. His additional honors include the American Academy of Ophthalmology’s Senior Achievement Award, the Distinguished Physician Award from the Minority Health Institute, the Herbert W. Nickens Award from the Association of American Medical Colleges, and the NIH Director’s Award.
Debrework Zewdie, PhD
Dr. Debrework Zewdie, Distinguished Scholar at the Graduate School of Public Health and Health Policy of the City University of New York (CUNY) and Senior Leadership Fellow at Harvard University’s T.H. Chan School of Public Health, is a committed, dynamic, and inspiring public health leader with more than 35 years of experience in international development. Most of her career has been dedicated to mitigating the cross-sectorial impact of the HIV epidemic, women’s empowerment, and poverty.
Over the course of 16 years, Dr. Zewdie has held several key leadership positions at The World Bank, including Manager of the AIDS Campaign for Africa (1999-2002) and Lead Population and Reproductive Health Specialist for the Africa Region (1994-1999). During her tenure, she conceptualized and managed the groundbreaking US$1 billion multi-country HIV/AIDS Program that changed the AIDS funding landscape and pioneered the large scale multi-sectoral response with direct financing to civil society and the private sector. As Director of The World Bank’s Global HIV/AIDS Program, she provided strategic vision and direction for the coordinated resource mobilization efforts of a global HIV/AIDS funding portfolio totaling US$4 billion.
Dr. Zewdie also served in several pivotal roles that contributed to the transformation of The Global Fund, serving as Interim Director of Country Programs (2007-2008), Deputy Executive Director (2010-2012), and Deputy General Manager (2012-2013).
In addition to her work with these leading multilateral organizations, Dr. Zewdie was Deputy Regional Director and Special Assistant to the Director for FHI 360’s USAID-funded AIDS Control and Prevention Project in the Africa Region (1992-1994). In this capacity, she established and managed a highly effective regional office, providing managerial and technical guidance to staff, leading teams and developing short- and mid-term HIV plans for 17 African countries in coordination relevant stakeholders. She acted as focal point for AIDS programming for women.
Dr. Zewdie’s earlier professional experience includes work as a Senior Program Manager for the Ethiopian Ministry of Health’s AIDS/STD Prevention and Control Program (1991-1992), where she forged a strong foundation for the development of a multi-sectoral approach to HIV-related treatment, care, and prevention; Deputy Director and Head of the Referral Laboratory for AIDS at the National Research Institute of Health in Addis Ababa (1988-1991), where she supervised day-to-day operation of the diagnostic laboratories, trained laboratory technicians, established quality assurance systems, and set up a network of 34 screening laboratories in all blood banks and regional hospitals across Ethiopia; and Acting Director of the Ethiopian National Research Institute of Health (1986-1989) — now part of the Ethiopian Public Health Institute —, where she oversaw the work of 300 staff members, managed grants from UNDP, WHO/TDR, and other donor agencies, and played a pivotal role in the development of the Ministry of Health’s Health Research Committee, which was responsible for enhancing research capacity and setting priorities for health research in the country.
Dr. Zewdie earned a Ph.D. in clinical immunology at the University of London; completed a post-doctoral fellowship in microbiology at SYVA, a diagnostic company in Palo Alto, California, and an international laboratory training on the molecular and cellular aspects of immunology at the Weizmann Institute of Science in Rehovot, Israel; and was a Senior MacArthur Fellow at Harvard University in Cambridge, Massachusetts. She graduated from Addis Ababa University with a B.Sc. in biology.
Dr. Zewdie has published articles on a broad range of subjects in more than 100 journals and textbooks, and serves on a number of nonprofit Boards and scientific committees.
Roger J. Bulger, MD (retired December 2015)
Dr. Bulger was president and CEO of theAssociation of Academic Health Centers(AAHC) from 1988 until his retirement in 2005. AAHC is a nonprofit organization that seeks to advance the nation’s health and well-being through vigorous leadership of the nation’s more than 100 academic health centers.
Dr. Bulger has served as a senior consultant to the Director of the National Institutes of Health’s National Center on Minority Health and Disparities. He is currently serving as the chairperson of the Board of Directors at theInstitute for the Advancement of Multicultural and Minority Medicine. Previous positions include president of the University of Texas Health Science Center (1978-1988); chancellor of the University of Massachusetts Medical Center(1976-1978); and executive officer at the Institute of Medicine of theNational Academy of Sciences (1972-1976).
Dr. Bulger has authored or edited nine books on medical issues and health policy, and his tenth — titled “Healing America: Hope, Mercy, Justice, and Autonomy in Health Care” — is currently in press.
Dr. Bulger received the President’s Award of the American Academy of Family Practice and the Distinguished Service Award from the Association of Schools of Allied Health Professions. He is an elected member of the Institute of Medicine of the National Academies and of the National Academy for Social Insurance. He is a Fellow of numerous professional associations and organizations, including the Infectious Disease Society of America, the American College of Physicians, the Royal College of Physicians, and Academy Health (the Association for Health Services Research). Dr. Bulger served on the AIHA Board of Directors since 1992, including terms as secretary (2004-2008) and treasurer and chair of the Finance and Audit Committee since 2009. Following his retirement from our Board of Directors in December 2015, he remains a Member Emeritus.
Daniel P. Bourque, MBA (emeritus)
Prior to retirement, Mr. Bourque was group senior vice president of field services at VHA Inc., a nationwide member network of community-owned healthcare systems and their associated physicians. His responsibilities included overseeing eight area offices: VHA Central Atlantic, VHA East Coast, VHA Empire-Metro, VHA Georgia, VHA New England, VHA Northeast, VHA Pennsylvania, and VHA Southeast. He previously served as VHA’s senior vice president for corporate and public affairs.
Previous positions have included president of the National Committee for Quality Health Care (1984-1986); deputy administrator of the Health Care Financing Administration (1982-1984); and deputy executive secretary of the U.S. Department of Health and Human Services (1981-1982).
Mr. Bourque was also a professional staff member of the U.S. Senate Labor and Human Resources Health Subcommittee and served as the associate director of a Robert Wood Johnson Foundation national grant program. Currently, Mr. Bourque serves on the boards of the David A. Winston Health Policy Fellowship and Partnership for Prevention.
A member of the AIHA Board of Directors since 1992, Mr. Bourque served as AIHA’s first chairman from 1992 to 1998.
Henry A. Fernandez, JD (retired April 2017)
Attorney Fernandez is the Associate Commissioner for Adult Services with the New York State Office of Mental Health (OMH). He is an executive, attorney, judge, public official, and educator with more than years of diverse experience in the public and private sectors. From 1981 to 1986, he served in the OMH Office of Counsel as Assistant Counsel and from 1986 to 1988 in the Capital District Psychiatric Center as Director for Administration. Prior to leaving the OMH in 1988, he organized the newly established Bureau of Investigation and Audit and served as its first Director. He was appointed Deputy Commissioner for the Professions with the New York State Education Department (SED) where he served from 1988 to 1993. In 1991, the Ford Foundation and Harvard University recognized his Nursing Initiative at SED as one of the nation’s top innovative programs in state and local government. While at SED, Attorney Fernandez established the Office of State Review and served as the first State Review Officer on appeals from parents or school districts regarding the placement of children with handicapping conditions pursuant to federal law.
Attorney Fernandez’s experience in complex and diverse matters spans the healthcare field and higher education. Prior to returning to state service, he served as the Village Justice in Cooperstown, New York, as well as held several leadership and executive positions in the private sector. He has managed international and domestic healthcare engagements and management training programs in Central and Eastern Europe, Eurasia, and Latin America, as well as in the public and private healthcare sectors throughout the United States. Attorney Fernandez served as president and CEO of the Association of University Programs in Health Administration (1992-1998). He is a member of the New York State Bar and the federal courts. He is an elected Fellow of the New York State Bar Foundation and he is also an elected Fellow of the New York Academy of Medicine.
Attorney Fernandez holds a Bachelor of Arts from St. John’s University and a Juris Doctor from the Brooklyn Law School. He has completed the National Institute for Trial Advocacy Program at Cornell University and the Program for Senior Executives in State and Local Government at the John F. Kennedy School of Government, Harvard University. He has served on AIHA’s Board of Directors since 1993.
Larry S. Gage, JD (retired April 2017)
Attorney Gage is a senior counsel at Alston and Bird, LLP. His practice is focused primarily on public sector and nonprofit health law and policy. He was the founding president of the National Association of Public Hospitals and Health Systems (NAPH). NAPH members include more than 100 of the nation’s largest urban teaching hospitals and health systems serving a disproportionate percentage of publicly sponsored patients. The association supports the development of innovative approaches to public sector health delivery, including the integration of managed care, primary care, and public health. NAPH provides interpretation of laws, regulations, policies and practices, and educational and training programs for public hospital personnel and, in a joint venture with the University Health System Consortium, provides group purchasing and bench marking studies.
Attorney Gage has carved out a unique entrepreneurial role in public sector healthcare during his 35 years of practice and government service. The National Law Journal recognized Attorney Gage for this work, naming to its latest list of “100 Most Influential Lawyers in America”. He is a prolific writer and frequently lectures on topics including hospital governance and legal structure, healthcare for the uninsured, Medicaid policy, medical school affiliation agreements, managed care, and international health.
Attorney Gage’s previous positions include deputy assistant secretary for Health Legislation, U.S. Department of Health and Human Services (1978-1981) and staff counsel, US Senate Labor and Human Resources Committee (1973-1977). He has served on the AIHA Board of Directors since 1992, and was secretary of the Board from 1992 to 1999 and chairman from 2000 to 2003.
Donald W. Fisher, PhD, CAE (March 2, 1946 – March 26, 2017)
“Don played such an essential, central role to the success of AIHA for almost a quarter of a century. His dedication and contribution to AIHA is so much a part of its fabric that I hardly know where to begin in describing his legacy,” said AIHA Board of Directors Chair, Dr. Dennis Andrulis.
“Don’s grounded brilliance and incisive thinking were his hallmarks for us as he lent such formidable experience to plans, progress, and direction … we all looked to him for his insights, thoughts, and guidance. All this and so much more he did with grace, humor, and ease,” Dr. Andrulis continued.
Dr. Fisher led the American Medical Group Association (AMGA) — formerly called the American Group Practice Association — as its President and Chief Executive Officer since 1980. In that capacity, he helped shape the organization into a leading voice of the nation’s most prestigious multi-specialty medical groups and integrated systems of care.
As a guiding force driving AIHA’s growth and development through our initial years as one of the first organizations working on health sector reform in the countries of the former Soviet Union, Dr. Fisher was able to tap into not only his own wealth of knowledge and experience in coordinated, integrated health service delivery systems, but also that of AMGA’s constituency — many of which served as U.S. partner institutions over the years. His wisdom and leadership were equally crucial as AIHA expanded beyond Eurasia in 2004, adapting our unique twinning model to strengthening institutions that provide HIV/AIDS-related training and services in sub-Saharan Africa and later Asia and the Caribbean.
As a founding member of AIHA’s Board of Directors, Dr. Fisher served as treasurer and chairman of the Finance and Audit Committee from 1992 to 1999, as secretary from 2000 to 2003, and as chair from 2004 to 2008.
“Don was an integral part of AIHA from the beginning and a true mentor in every sense of the word,” said James P. Smith, founding Executive Director of AIHA until his retirement in early 2015.
David Greeley, who joined AIHA as President and Chief Executive Officer in 2015, agreed, saying, “Don’s support during AIHA’s leadership transition and guidance over the past two years as we’ve worked to expand both geographically and programmatically has been invaluable.”
Dr. Fisher is survived by his children, Kim Hayman and Jeff Fisher, and their respective families. On behalf of AIHA’s Board of Directors, staff, and partners around the globe, we extend our deepest sympathies to them.
“All who have been with Don on AIHA’s Board know the magnitude of the loss,” Dr. Andrulis said. “For our new members, I know I speak for all that we regret that you will not have the opportunity to spend time in his company.”
If you would like to send condolences to Dr. Fisher’s family, please visit amga.org.